NCT07473401

Brief Summary

The aim of the present study is to gain more information about retinal functional parameters in myopic children in Europe. For this purpose, a prospective case-control study in children aged between 8 and 13 years, as this is the usual age of myopia onset, will be conducted. Forty myopic children will be age- and sex-matched to non-myopic controls. Retinal oxygen extraction will be used as the main outcome parameter, as data from animal and human studies point towards an involvement of hypoxia in the disease process. In addition, other parameters probably linked to myopia will be investigated, such as retinal and choroidal blood flow as well as choroidal and retinal vessel density and anatomical structures such as choroidal and central retinal thickness. Also, questionnaires about lifestyle factors will be completed.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for all trials

Timeline
5mo left

Started May 2026

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress36%
May 2026Jan 2027

First Submitted

Initial submission to the registry

December 11, 2025

Completed
3 months until next milestone

First Posted

Study publicly available on registry

March 16, 2026

Completed
2 months until next milestone

Study Start

First participant enrolled

May 11, 2026

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 2, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 2, 2027

Last Updated

March 16, 2026

Status Verified

March 1, 2026

Enrollment Period

8 months

First QC Date

December 11, 2025

Last Update Submit

March 10, 2026

Conditions

Keywords

Retinal oxygen extractionblood flowVessel density

Outcome Measures

Primary Outcomes (1)

  • Retinal oxygen extraction

    Retinal oxygen extraction measured with LSFG and RVA

    Study Day 1

Secondary Outcomes (7)

  • Choroidal and retinal blood flow

    Study Day 1

  • Choroidal and central retinal thickness

    Study Day 1

  • Retinal and choroidal vessel density

    Study Day 1

  • Lifestyle factors

    Study Day 1

  • Axial eye length

    Study Day 1

  • +2 more secondary outcomes

Study Arms (2)

children with myopia

children with myopia

healthy age- and sex-matched controls

healthy age- and sex-matched controls

Eligibility Criteria

Age8 Years - 13 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

40 children with myopia and 40 healthy age- and sex-matched controls

You may qualify if:

  • Children aged between 8 and 13 years (inclusive)
  • Signed informed consent of child and legal guardian
  • Normal ophthalmic findings except myopia
  • Cycloplegic spherical equivalent (SE) refraction ≤ -1.0dpt in both eyes
  • Normal findings in the medical history unless the investigator considers an abnormality to be clinically irrelevant
  • Children aged between 8 and 13 years (inclusive)
  • Signed informed consent of child and legal guardian
  • Normal ophthalmic findings
  • Cycloplegic spherical equivalent (SE) refraction between +0.5dpt and -0.5dpt
  • Normal findings in the medical history unless the investigator considers an abnormality to be clinically irrelevant

You may not qualify if:

  • Intake of stimulating beverages containing xanthine derivatives (tea, coffee, cola-like drinks) 12 hours before the study day
  • Previous eye abnormalities such as cataract, keratopathy, strabismus, amblyopia, ocular inflammation, trauma, or surgery
  • History of any disease or syndrome associated with severe myopia such as Marfan syndrome, Stickler syndrome, or retinopathy of prematurity
  • Non-axial cause of myopia
  • BCVA less than 20/25
  • Intraocular pressure ≥ 21mmHg
  • Astigmatism ≤ -1.0dpt
  • Anisometropia ≥ 2dpt
  • Not able to read letters for visual acuity testing

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Clinical Pharmacology, Medical University of Vienna, Austria

Vienna, 1090, Austria

Location

MeSH Terms

Conditions

Myopia

Condition Hierarchy (Ancestors)

Refractive ErrorsEye Diseases

Study Officials

  • Doreen Schmidl-Schordje, MD, PhD

    Department of Clinical Pharmacology, Medical University of Vienna

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Doreen Schmidl-Schordje, MD, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assoc. Prof. Priv. Doz. Dr., PhD

Study Record Dates

First Submitted

December 11, 2025

First Posted

March 16, 2026

Study Start

May 11, 2026

Primary Completion (Estimated)

January 2, 2027

Study Completion (Estimated)

January 2, 2027

Last Updated

March 16, 2026

Record last verified: 2026-03

Locations